SatyaDasMDMSCI

PubMed

• 1569 citations
  Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
  Daniel Y. Wang, Joe-Elie Salem, Justine V. Cohen, Sunandana Chandra, Christian Menzer
  JAMA Oncology. 2018-12-01
• 628 citations
  Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors.
  Satya Das, Douglas B. Johnson
  Journal for Immunotherapy of Cancer. 2019-11-15
• 153 citations
  Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?
  Satya Das, Arvind Dasari
  Current Oncology Reports. 2021-03-14

Journal Articles

• Harnessing the Immune System in Pancreatic Cancer  
  Satya Das, Jordan Berlin, Dana Cardin, Current Treatment Opinions in Oncology, 8/13/2018
• Hidden Figures: Occult Intra-Cardiac Metastases in Asymptomatic Neuroendocrine Tumor Patients  
  Satya Das, Gino Pineda, Jordan Berlin, Brian Hemphill, Javid Moslehi, Anju Nohria, George Fisher, Journal of Oncology and Cancer Research, 7/26/2018
• Quality Matters: Immunotherapy and the Evolving Landscape of Advanced Cancer Care  
  Das S, Horn L, Expert Review of Quality of Life in Cancer Care, 1/1/2017
• Plasma Genotyping in Patients with Non-Small Cell Lung Cancer: Simplifying or Confusing the Diagnosis?  
  Das S, Horn H, Lung Cancer Management, 1/1/2017
• Surrogate or Not: The Role for Cell Free Circulating DNA in Detecting EGFR mutations Present in Tumor Tissue  
  Das S, Bazhenova L, Singh V, Arnold L, Alexiadis V et al, Journal of Thoracic Oncology, 1/1/2015
• How Long Is Too Long- The Safe Use of Maintenance Bevacizumab in Advanced Stage Non-Small Cell Lung Cancer  
  Das S, Bazhenova L, Lung Cancer Management, 1/1/2015
• Comparison of Image Guided Radiotherapy (IGRT) Technologies for Prostate Cancer  
  Das, S; Liu T, Jani AB, Rossi P, Shelton J, Shi J, Khan MK, American Journal of Clinical Oncology, 1/1/2014
• Clinically Significant Difference in Prostate Localization Using Daily Cone Beam CT (CBCT) and Electromagnetic Transponders  
  Khan M, Das S, Ogunleye T, Jani A, Rossi P et al, Practical Radiation Oncology, 1/1/2013
• Patterns of Failure in Advanced Stage Diffuse Large B-cell Lymphoma (DLBCL) Patients Treated with R-CHOP Chemotherapy and the Emerging Role of Consolidative Radiotherapy  
  Shi Z, Das S, Okwan-Duoudu D, Esiashvili, Flowers C, Jiang K, Chen Zhengjia, and Khan MK, International Journal of Radiation Oncology, Biology, Physics, 1/1/2013
• Renewed Interest in the Role of Consolidative Radiotherapy in Advanced Stage Diffuse Large B-Cell (DLBCL) Lymphoma  
  Shi Z; Eshiashvili N, Flowers C, Das S, and Khan MK, Leukemia and Lymphoma, 1/1/2013
• Join now to see all

Abstracts/Posters

• A phase II study of M6620 and irinotecan in TP53 mutant gastric and gastroesophageal junction (GEJ) adenocarcinoma patients (pts) [NCT03641313].
  Satya Das, Jennifer Whisenant, Austin Doyle, Carmen Joseph Allegra, Jordan Berlin, GI ASCO, San Francisco, 1/2019
• Peritoneal carcinomatosis (PC) in well-differentiated (WD) small-intestinal neuroendocrine tumor (SI-NET) patients (Pts) with mesenteric tumor deposits (MTDs)
  Satya Das, Chanjuan Shi, Tatsuki Koyama, Yi Huang, Raul S. Gonzalez, Kamran Idrees, Christina Edwards Bailey, Jordan Berlin, GI ASCO, 1/2019
• Peritoneal carcinomatosis (PC) in well differentiated small intestinal neuroendocrine tumors (SI-NET)
  Satya Das, Chanjuan Shi, Tatsuki Koyama, Jordan Berlin, ASCO, Chicago, 6/2018
• Novel PET/CT imaging biomarkers of CB-839 in combination with panitumumab and irinotecan in patients with metastatic and refractory RAS wildtype (WT) colorectal cancer...
  Satya Das, Dana Cardin, Laura Goff, Jordan Berlin, Michael Schulte, H. Charles Manning, Robert Coffey, Jennifer Whisenant, Rachel Krumsick, Kristen Ciombor, ASCO, Chicago, 6/2018
• Adenocarcinoma Ex Goblet Cell: A Retrospective Experience
  Satya Das, Jordan Berlin, Liping Du, Kamran Idrees, Chanjuan Shi, GI ASCO, San Francisco, 1/2018
• CtDNA assay to detect EGFR mutations and mechanisms of resistance to EGFR tyrosine kinase inhibitors
  Bazhenova L, Das S, Patel S, Arnold L, Singh V, J Clin Oncol, 2016 ASCO Annual Meeting, 1/1/2016
• Join now to see all

Lectures

• A phase II study of enterade in neuroendocrine tumor (NET) patients with quality-of-life limiting bowel movement frequency. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
• Neuroendocrine Tumors: An Overview 
  2019 NCAN Tennessee NET Patient Conference - 9/14/2019
• The Role for Cell Free Circulating DNA in Detecting Secondary EGFR Mutations in Advanced Stage Non-Small Cell Lung Cancer Patients 
  San Diego, CA - 1/1/2015

Other

• Phase II study of the Multikinase Inhibitor of Angiogenesis, Linifanib, in Patients with Metastatic and Refractory Colorectal Cancer Expressing Mutated KRAS - Beyond t... 
  Das S
  http://onctoday.com/beyond-the-abstracts/colorectal/47926-phase-ii-study-of-the-multikinase-inhibitor-of-angiogenesis-linifanib-in-patients-with-metastatic-and-refractory-colorectal-cancer-expressing-mutated-kras-beyond-the-abstract.html